Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
View Older Stories
-
Cellebrite (CLBT) PT Lowered to $15 at TD Cowen
-
TD Cowen: 'CABA appears well-positioned to scale commercially with minimal capital investment'
-
Invesco (IVZ) PT Raised to $39 at TD Cowen
-
'eToro Group (ETOR) Back To Show Me Status'; PT Lowered to $35 at TD Cowen
-
TD Cowen on Virgin Galactic (SPCE): 'increasingly confident in the durability of demand'
-
Navan Inc (NAVN) PT Raised to $34 at TD Cowen
-
Circle Internet Group (CRCL) PT Raised to $87 at TD Cowen
-
Lumentum (LITE) PT Raised to $820 at TD Cowen
-
Summitt Midstream Corp. (SMC) PT Raised to $43 at TD Cowen
-
Calumet Specialty Products Partners (CLMT) PT Raised to $40 at TD Cowen
-
CAVA Group Inc (CAVA) PT Lowered to $85 at TD Cowen
-
CoreWeave (CRWV) PT Raised to $87 at TD Cowen
-
FocalTherics prices public offering of 8.4 million ADS at $4.75 each
-
FocalTherics proposes public offering of American Depositary Shares
-
Cheniere Energy (LNG) PT Raised to $290 at TD Cowen
-
CEVA Inc. (CEVA) PT Lowered to $45 at TD Cowen
-
Intuit (INTU) PT Raised to $328 at TD Cowen
-
TD Cowen Starts Valneva SE (VALN) at Buy
-
TD Cowen Reiterates Top Pick on General Motors (GM)
-
TD Cowen: 'Revolution (RVMD) Firing On All Cylinders'
-
Charles River Labs (CRL) PT Raised to $300 at TD Cowen
-
Diageo PLC. (DGE:LN) (DEO) PT Raised to GBP20.40 at TD Cowen
-
e.l.f. Beauty (ELF) PT Raised to $110 at TD Cowen
-
TD Cowen Upgrades Sezzle Inc (SEZL) to Buy 'on more compelling valuation'
-
Avere Therapeutics raises $500M in private placement for drug program
-
TD Cowen Starts Csquare Inc (CSQR) at Buy
-
TD Cowen sees 25% chance Trump will succeed removing Fed's Cook
-
TD Cowen Downgrades Inter Parfums (IPAR) to Hold
-
Energy Transfer (ET) PT Raised to $25 at TD Cowen
-
TD Cowen Downgrades ATS Corporation (ATS:CN) (ATS) to Hold
-
Braveheart Bio raises $439.9M in upsized Nasdaq IPO
-
Twilio (TWLO) PT Raised to $260 at TD Cowen
-
Atlassian Corporation (TEAM) PT Raised to $145 at TD Cowen
-
RXO, Inc. (RXO) PT Lowered to $17.50 at TD Cowen
-
Cloudflare Inc. (NET) PT Raised to $355 at TD Cowen
-
TD Cowen Upgrades DaVita (DVA) to Buy
-
ExxonMobil (XOM) PT Raised to $168 at TD Cowen
-
TD Cowen Downgrades Ginkgo Bioworks Holdings Inc (DNA) to Hold
-
Roivant Sciences (ROIV) PT Raised to $50 at TD Cowen
-
TD Cowen Reiterates Buy Rating on Black Diamond Therapeutics (BDTX)
-
TD Cowen sees new open banking rule coming in weeks
-
Klaviyo Inc (KVYO) PT Lowered to $26 at TD Cowen
-
Freshpet (FRPT) PT Raised to $85 at TD Cowen
-
TD Cowen Upgrades TPG Inc. (TPG) to Buy
-
TD Cowen Starts Obsidian Therapeutics (OBX) at Buy
-
TD Cowen Downgrades Capri Holdings (CPRI) to Hold
-
Braveheart Bio prices IPO at $18 per share, raises $382.5M
-
Arista Networks (ANET) PT Raised to $250 at TD Cowen
-
Amgen (AMGN) PT Raised to $452 at TD Cowen
-
TD Cowen on AMD (AMD): 'Very Strong Outlook Against A Very High Bar'

